Pannu et al. [45] investigated anti-RhD immunoglobulin (anti-D), which blocks the Fcγ receptor and has previously demonstrated efficacy in improving platelet counts in patients with immune thrombocytopenic purpura (ITP) [53]. Here, RHD is linked to autoimmune thrombocytopenic purpura.